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Brainstem network pathology and impaired respiratory drive as successive 
signatures in a rat model of Parkinson’s disease  
 
Parkinson’s disease (PD) is a devastating neurodegenerative disorder. Progressive destruction of 
midbrain dopaminergic neurons and axonal projections of the nigrostriatal pathway disrupts circuitry 
within the basal ganglia controlling movement. Consequently, PD is characterised by motor 
impairment culminating in resting tremor, impaired voluntary movement, muscle rigidity and 
abnormal balance and posture, symptoms markedly affecting the quality of life of people with PD. 
Non-motor impairments also present in PD, including deficits in autonomic, sensory and cognitive 
function. Sleep is disturbed in PD and sleep-disordered breathing is a common comorbidity. Indeed, 
there appears to be a reciprocal association between PD and sleep-disordered breathing, particularly 
an increased risk of developing PD in people (and perhaps especially women) with obstructive sleep 
apnoea (Sheu et al., 2015). Dysphagia and poor upper airway control are features of PD, with 
aspiration pneumonia recognised as the leading cause of mortality. There is evidence of abnormal 
ventilatory control in the absence of lung disease in PD, but ventilatory dysfunction in PD is 
understudied despite recognition that respiratory insufficiency is a hallmark feature of other 
neurodegenerative diseases associated with increased morbidity and mortality. Increased awareness 
of early brainstem involvement in pre-motor manifestations of PD has awoken interest in the need for 
full characterisation of the extent of disability in PD. The search is on for prodromal signatures of 
clinical relevance. 
In this issue of Experimental Physiology, Fernandes-Junior et al. (2018) describe studies using an 
established experimental model of PD, which aimed to determine the temporal relationship between 
neuroanatomical changes in the brainstem and functional alterations in breathing. Adult male rats 
received bilateral injections of 6-hydroxydopamine (6-OHDA, a selective neurotoxin), or vehicle 
(control) into the caudate putamen of the striatum, which was confirmed after 30 days to produce 
>70% persistent loss of tyrosine hydroxylase-expressing neurons of the substantia nigra pars 
compacta of the midbrain. Neuroanatomical assessments of key brainstem sites governing respiratory 
control as well as measures of basal ventilation and ventilatory responsiveness to carbon dioxide in 
conscious animals were assessed 30, 40 and 60 days after induction of the model.  
Using immunohistochemistry, Fernandes-Junior et al. (2018) revealed progressive widespread 
brainstem neuron and astrocytic glial cell loss in rhythmogenic, integrative and chemosensitive sites 
of the central respiratory network. Portrayed in the study is evidence, by day 30 in 6-OHDA rats 
compared with control rats, of fewer phox2b immuno-reactive neurons both in the nucleus tractus 
solitarii (NTS, a key integrative, chemosensitive and relay hub of the respiratory network) and the 
retrotrapezoid nucleus (RTN, a key site of central chemoreception). Subsequently, by day 40, the 
density of neurokinin-1 receptors of the rostral ventrolateral respiratory group (rVRG) and pre-
Bötzinger complex (the principal rhythmogenic site of the medulla oblongata) was lower in 6-OHDA 
rats. In addition, the relative area of glial fibrillary acidic protein immuno-reactive astrocytes, which 
are implicated in respiratory control, was less in the rVRG (day 30), RTN (day 40), NTS (day 60) and 
pre-Bötzinger complex (day 60) of 6-OHDA rats. 
Using whole-body plethysmography, Fernandes-Junior et al. (2018) demonstrated reduced basal 
minute ventilation (day 40 and 60) in 6-OHDA rats owing to reductions in respiratory frequency (day 
40 and 60) and tidal volume (day 60). Similarly, in 6-OHDA rats, ventilation was depressed during 
hypercapnic breathing. Surprisingly, in the light of substantial cell loss in brainstem chemosensitive 
sites, ventilatory responsiveness to 7% inspired CO2 (∆ VE from respective baseline) was preserved at 
each time point of the study; although notably, 60 days after neurotoxic insult this was achieved by 
way of a different pattern of respiration compared with control animals, with significant blunting of 
the tidal volume response to CO2 in 6-OHDA rats. The preservation of hypercapnic ventilatory 
responsiveness is surprising given the fundamental roles of the RTN (Kumar et al., 2015) and NTS (Fu 
et al., 2017) in ventilatory responsiveness to CO2, but presumably relates to considerable redundancy 
in central mechanisms of chemosensitivity, which appear intact in this progressive model (as is the 
capacity to raise respiratory frequency), at least at this stage of the disease. Indeed, this group has 
demonstrated a key role for catecholaminergic neurons of the pontine locus coeruleus in driving 
hypercapnic breathing in PD animals. The new observations extend previous work by this research 
group, which collectively and convincingly demonstrate aberrant control of respiratory frequency 
under basal resting conditions and in response to chemosensory challenge. Interestingly, prior work 
by this group has established that indices of motor behaviour, including spontaneous locomotion, and 
motor coordination and balance are unaffected in 6-OHDA rats at the time of the emergence of 
respiratory impairments, revealing that altered respiratory control is a prodromal signature, a 
prophecy of the impending pathology of the pernicious disease. Fernandes-Junior et al. (2018) 
demonstrate that neuroanatomical changes in the brainstem precede the emergence of functional 
changes in respiratory homeostasis, but it is also worth noting that dysregulated breathing, blood gas 
derangements and disrupted cerebrovascular function in PD might well compound 
neurodegeneration establishing a vicious cycle and spiral of disability. Of interest, it is established that 
exposure to chronic intermittent hypoxia, modelling human sleep apnoea, causes oxidative stress and 
inflammation in the substantia nigra of rats (Synder et al., 2017).  
The work of Fernandes-Junior et al. (2018) reveals the need for comprehensive assessments of 
cardiorespiratory control in translational animal models of PD. Assessments of ventilation, 
metabolism and arterial blood gas and pH status are needed to fully characterize respiratory deficits 
in PD animals. Studies of respiratory control and plasticity during wakefulness and sleep are 
warranted. Further characterization of motor control of breathing, especially motor control of the 
upper airway, and respiratory muscle form and function is required, given the evidence of pharyngeal 
muscle remodelling in people with PD with confirmed dysphagia. It is also plausible that there are 
changes in modulatory circuits projecting to respiratory nuclei, which needs to be explored. 
Importantly, whereas the 6-OHDA model has utility, there is recognition of the need to better model 
the pathology of PD so as to recapitulate the destructive and debilitating qualities of the disease. The 
growing interest in nigrostriatal pathway degeneration, with preclinical evidence suggesting that early 
axonal loss may be especially important in early stage PD symptoms (O’Keeffe & Sullivan, 2018), 
highlights the importance of α-synuclein accumulation and Lewy pathology. Assessments of 
respiratory and autonomic control in α-synuclein models of PD will be an important extension to 
current experimental approaches and should provide insights directly relevant to human PD 
pathology. 
The elegant study of Fernandes-Junior et al. (2018), which adds to an impressive portfolio of progress 
in this area by this research group, provides impetus for the careful screening and characterisation of 
non-motor manifestations including aberrant respiratory control in PD and other neurodegenerative 
conditions. Onward! 
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